Risankizumab Resolves Psoriasis in Half of Patients

(MedPage Today) — Superior to ustekinumab for many endpoints in two RCTs Source: Dermatology

(MedPage Today) — Superior to ustekinumab for many endpoints in two RCTs
Source: Dermatology

Leave a Reply